Related Experiment Video
Updated: Jun 4, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Bacteriological Profile of Patients With Stroke-Associated Pneumonia and Antimicrobial Susceptibility of Pathogens: A
Smrutisree Mohapatra1, Basanti Kumari Pathi1, Ipsa Mohapatra2
1Microbiology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Background And Objectives:
Stroke-associated pneumonia (SAP) is the aftermath of aspiration of oropharyngeal secretions or stomach content. Mechanical ventilation and lowered immunity and consciousness facilitate the etiopathogenesis of SAP. Antibiotic prophylaxis and repeated culture and sensitivity testing dampen the drug susceptibility patterns of the pathogens. We accomplished this study to determine the bacteriological profile of patients with SAP and the antimicrobial susceptibility patterns of the pathogenic bacteria.
Methods:
This cross-sectional study was executed from August 2022 to May 2024 at Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, India. We included adult patients who endured treatment in the neurosurgery intensive care unit (ICU) throughout the study period due to a stroke and developed pneumonia within 48 hours of admission. The endotracheal tube (ET) aspirate and bronchoalveolar lavage (BAL) fluid specimens collected from the eligible participants were analyzed. Enriched and selective media such as 5% sheep blood agar, chocolate agar, and MacConkey agar were used to culture pathogenic bacteria. The VITEK 2 system was used to identify isolates and assess antimicrobial susceptibility testing (AST). The pathogenic bacteria and their antimicrobial susceptibility patterns were gauged. We leveraged R software (version 4.4.1) for data analysis.
Results:
Two hundred forty bacterial isolates were found in the 181 eligible patients. Forty-eight (26.52%) participants were females. The median age of the study population was 64.50 (58.74-70.24) years. Fifty-nine (32.60%) participants had two different isolates in their culture reports. We found the following non-fermenters: Acinetobacter baumannii (55, 22.92%), Pseudomonas aeruginosa (31, 12.92%), Burkholderia cepacia (6, 2.50%), and Elizabethkingia meningoseptica (4, 1.67%). Klebsiella pneumoniae (88, 36.67%) and Escherichia coli (15, 6.25%) were the most commonly noticed Enterobacterales. Other Enterobacterales were Proteus mirabilis (9, 3.75%), Serratia marcescens (8, 3.33%), Klebsiella oxytoca (3, 1.25%), Enterobacter aerogenes (1, 0.42%), Providentia stuartii (1, 0.42%), and Enterobacter cloacae complex (5, 2.08%). Staphylococcus aureus (14, 5.83%) was the only gram-positive cocci in our study population. The sensitivity of A. baumannii was maximum for minocycline. P. aeruginosa was highly sensitive to imipenem and completely resistant to tigecycline. Minocycline was the only effective drug against E. meningoseptica. Similarly, the Enterobacterales had the greatest sensitivity for tigecycline. All 14 specimens of S. aureus were sensitive to both vancomycin and linezolid. They were responsive to tigecycline as well.
Conclusion:
The most common pathogenic bacteria in our study were K. pneumoniae, A. baumannii, P. aeruginosa, E. coli, and S. aureus. Enterobacterales were highly sensitive to tigecycline. A. baumannii and E. meningoseptica had maximum sensitivity for minocycline. All isolates of S. aureus were sensitive to both vancomycin and linezolid. We warrant further research with a larger sample size to investigate the bacteriological profile among other critically ill patients and their AST findings.
Insights
Stroke-associated pneumonia (SAP) in neurosurgery ICU patients is often caused by Klebsiella pneumoniae and Acinetobacter baumannii. Tigecycline and minocycline show high effectiveness against common pathogens, guiding antibiotic strategies.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Stroke-associated pneumonia (SAP) arises from aspiration, exacerbated by mechanical ventilation, immunosuppression, and reduced consciousness.
- Prior antibiotic use can alter pathogen susceptibility patterns, complicating treatment.
- Understanding the specific bacteriology of SAP is crucial for effective management.
Purpose of the Study:
- To determine the bacteriological profile of pathogens causing SAP in neurosurgery ICU patients.
- To assess the antimicrobial susceptibility patterns of these identified bacteria.
Main Methods:
- A cross-sectional study conducted in a neurosurgery ICU from August 2022 to May 2024.
- Analysis of endotracheal tube aspirates and bronchoalveolar lavage fluid from adult stroke patients with pneumonia.
- Bacterial identification and antimicrobial susceptibility testing (AST) performed using the VITEK 2 system.
Main Results:
- Klebsiella pneumoniae (36.67%) and Acinetobacter baumannii (22.92%) were the most prevalent pathogens.
- Pseudomonas aeruginosa (12.92%) and Escherichia coli (6.25%) were also frequently isolated.
- Acinetobacter baumannii showed maximum sensitivity to minocycline; Enterobacterales were highly sensitive to tigecycline; Staphylococcus aureus was sensitive to vancomycin and linezolid.
Conclusions:
- Key pathogens in SAP include K. pneumoniae, A. baumannii, P. aeruginosa, E. coli, and S. aureus.
- Tigecycline, minocycline, vancomycin, and linezolid demonstrate significant efficacy against specific SAP pathogens.
- Further research with larger cohorts is recommended to explore bacteriology and AST in critically ill patients.
More Related Videos
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Special Staining Techniques